Palang Chotsiri
Senior Scientist, Clinical Pharmacology
Currently a senior scientist at MORU's Department of Clinical Pharmacology, Palang is a trained physicist. He uses pharmacokinetic and pharmacodynamic modelling and simulation as his main research tools. The use of mathematical and statistical modelling to solve biological problems fascinates Palang, since he can use mathematical equations to translate data into meaningful and impactful outcomes. Palang holds a PhD in Tropical Medicine, focusing on optimising anti-malarial drug regimens in several populations.
Palang's research aims to characterise the pharmacokinetic and pharmacodynamic properties of anti-infectious drugs in vulnerable populations, with the goal of optimising treatment and chemoprevention in these populations while also providing evidence to inform global treatment policies. Additionally, he intends to advance pharmacometric modelling methodologies to facilitate research in this field and communicate with a wider scientific community.
Recent publications
-
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Journal article
Peto TJ. et al, (2022), The Lancet Infectious Diseases
-
Mechanistic Modelling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity.
Journal article
Chotsiri P. et al, (2021), Clinical pharmacology and therapeutics
-
Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy
Journal article
Chotsiri P. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
-
Evaluating the Impact of Intervention Strategies on the First Wave and Predicting the Second Wave of COVID-19 in Thailand: A Mathematical Modeling Study.
Journal article
Mahikul W. et al, (2021), Biology, 10
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Journal article
Chotsiri P. et al, (2019), Nature Communications, 10